An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 204312
Company: EUGIA PHARMA

Products on ANDA 204312

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
LEVETIRACETAM	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 204312

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/01/2016	ORIG-1	Approval			Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204312Origs000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/204312Orig1s000ltr.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/21/2025	SUPPL-13	Labeling-Package Insert		Label is not available on this site.
05/22/2023	SUPPL-9	Labeling-Package Insert		Label is not available on this site.
04/20/2020	SUPPL-8	Labeling-Package Insert		Label is not available on this site.
04/20/2020	SUPPL-6	Labeling-Package Insert		Label is not available on this site.
04/20/2020	SUPPL-4	Labeling-Package Insert		Label is not available on this site.
04/20/2020	SUPPL-2	Labeling-Package Insert		Label is not available on this site.

Labels for ANDA 204312

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/01/2016	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204312Origs000lbl.pdf

Therapeutic Equivalents for ANDA 204312

LEVETIRACETAM

INJECTABLE;INTRAVENOUS; 500MG/5ML (100MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
KEPPRA	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	Yes	AP	021872	UCB INC
LEVETIRACETAM	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	No	AP	204312	EUGIA PHARMA
LEVETIRACETAM	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	No	AP	090876	FRESENIUS KABI USA
LEVETIRACETAM	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	No	AP	209781	HAINAN POLY PHARM
LEVETIRACETAM	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	No	AP	090981	HIKMA FARMACEUTICA
LEVETIRACETAM	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	No	AP	202869	HOSPIRA INC
LEVETIRACETAM	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	No	AP	215465	KNACK
LEVETIRACETAM	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	No	AP	211954	MICRO LABS
LEVETIRACETAM	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	No	AP	215980	MSN
LEVETIRACETAM	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	No	AP	203308	MYLAN LABS LTD
LEVETIRACETAM	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	No	AP	209474	PRINSTON INC
LEVETIRACETAM	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	No	AP	091627	SAGENT PHARMS
LEVETIRACETAM	LEVETIRACETAM	500MG/5ML (100MG/ML)	INJECTABLE;INTRAVENOUS	Prescription	No	AP	091485	XGEN PHARMS

Top